Re: US healthcare system
**Some additional statistics on healthcare in the industrialized world:
***Waiting times *
- Patients having to wait more than four months for surgery, by country - **US 5%**, Aus 23%, NZ 26%, Can 27%, Britain 36% (Schoen, Blendon, DesRoches, Osborn "Comparison and HEalth Care Systtem Views and Experiences in Five Nations, 2001" Commonwealth Fund, May 2002/ Harvard School of Public Health) Public Health)
of people who get surgery..
Equality
- **Low income people in the US without job-related insurance spend only about $50 more out of pocket for health than those with**, 2.4 visits to doctor each year (3.4 without). When they are seriously ill, they receive same level of treatment (Johnson and Crystal, "Uninsured Status and Out of Pocket Costs at Midlife', Health Services Research 35, no 5, Dec 2000)
that does not explain the high levels of preventable deaths in US. they may be spending marginally more out of pocket but they are not getting the level of care they need otherwise we would not be rock bottom on that list.
Advanced technology
- **In availability of advanced medical technology, Canada ranks last out of the 29 OECD countries** ('It's the Prices, Stupid: Why the United States is so Different from Other Countries' Anderson, Reinhardt, Hussey and Petrosyan, Health Affairs, vol 22, no 3, May 2003)
- MRI units per capita: 2.5 canada, 3.9 UK, **8.1 US**; CT scanners, **13.6 US**, 8.2 Can, 6.5 UK, Lithotripsy units **1.5 US**, .4 Can, .2 UK (ibid)
- Coronary bypass (per 100,000 people per yr), **203 US**, 65 Can, 41 UK, coronary angioplasty **388.1 US,** 80.8 Can, 51 UK, renal dialysis **US 86.5**, Can 45.7, UK 27
No one is denying that US level of care is great for ppl who have access to it. but many dont.
as far as coronary bypass and angiplasty, lets also normalize that data with the prevelance of obesity and heart diease in US vis a vis other nations.
Prescription drugs
- Only one in five drugs tested ever makes the market, averaging $900 million in costs for each new drug (Press release, "Total Cost to Develop a New Prescription Drug, Including Cost of Post-approval Research, is $897 Million" May 13, 2003, Tufts Center for the Study of Drug Development)
I know drug companies better than most here. But the prices of prescription drugs are higher in US. the expense on R&D and all needs to be spread equally internationally.
- Economist Patricia Danzon discovered, excluding generic drugs (42% of US purchases), ignoring different consumption patterns, and ignoring rebates as a result of controlled study, comparing between 187 to 484 products, average prices in Canada, Germany, Sweden and Switzerland higher than in the US, but France, Italy, Japan, and the UK are lower. **But when variations of income are accounted for, prices in the US are lower than all except France **(Danzon, 'The Uses and Abuses of International Price Comparisons' in 'Competitive Strategies in the Pharmaceutical Industry, R. B. Hems (AEI press 1996), also 'Pharmaceutical Price Regulation: National Policies Versus Global Interests (AEI 1997)
wow, very recent research, and did they factor in that most insured ppl are limited by the PBM policies and even the formulary that the PBM decides. Shop around? sorry but in our system if u want to shop for pharma out of PBM u get screwed royally.
- By shopping around, best price shopping versus Canadian drugs,** for seven of ten drugs, US buyers can lower their costs an average of 38% below Canadian price**, and all **ten drugs produces average cost of 10% below buying in Canada **(Survey of pharmaceutical websites by 'Lives at Risk: Single Payer Health Insurance Around the World')
shopping around sounds good in theory but in reality it is next to impossible.
so in essence all is hunky dory when it comes to healthcare in US. is that what you are trying to establish? :)